Ministry of Industry and Information Technology: Accelerate the research and development of key core technologies, strengthen the resilience and security level of the pharmaceutical industry chain.

On October 28, 2025, the Department of Industry and Information Technology organized a symposium on the management of the pharmaceutical industry and key work on the industrial chain in Nanchang, Jiangxi Province. The meeting emphasized that the Fourth Plenary Session of the Twentieth Central Committee of the Communist Party of China has pointed out the direction for promoting the high-quality development of the pharmaceutical industry in the "15th Five-Year Plan" and beyond, and provided fundamental principles. The entire industry should conscientiously study and implement the spirit of the Fourth Plenary Session of the Twentieth Central Committee of the Communist Party of China, accurately grasp the changes in internal and external situations, continuously consolidate the steady recovery trend of the pharmaceutical industry, accelerate the breakthrough of key core technologies, strengthen the resilience and safety level of the pharmaceutical industry chain, enhance the supply of innovative drugs and medical devices, better meet the increasing health needs of the people, and accelerate the transformation of the pharmaceutical industry from scale expansion to innovation-driven critical breakthrough. The original text is as follows: The Department of Industry and Information Technology, through the Consumer Goods Industry, organized a symposium on the management of the pharmaceutical industry and key work on the industrial chain On October 28, 2025, the Department of Industry and Information Technology, through the Consumer Goods Industry, organized a symposium on the management of the pharmaceutical industry and key work on the industrial chain in Nanchang, Jiangxi Province. The meeting focused on various key tasks such as the operation of the pharmaceutical industry, statistical surveys, the high-quality development of the industrial chain, and the formulation of the "15th Five-Year Plan" for the development of the pharmaceutical industry, and conducted discussions and exchanges. Industrial and Information Technology authorities, relevant industry associations, affiliated institutions, support organizations, and other entities from various regions attended the meeting. The meeting emphasized that the Fourth Plenary Session of the Twentieth Central Committee of the Communist Party of China has pointed out the direction for promoting the high-quality development of the pharmaceutical industry in the "15th Five-Year Plan" and beyond, and provided fundamental principles. The entire industry should conscientiously study and implement the spirit of the Fourth Plenary Session of the Twentieth Central Committee of the Communist Party of China, accurately grasp the changes in internal and external situations, continuously consolidate the steady recovery trend of the pharmaceutical industry, accelerate the breakthrough of key core technologies, strengthen the resilience and safety level of the pharmaceutical industry chain, enhance the supply of innovative drugs and medical devices, better meet the increasing health needs of the people, and accelerate the transformation of the pharmaceutical industry from scale expansion to innovation-driven critical breakthrough. The meeting demanded the improvement of work mechanisms, the solid foundation of statistical surveys in the pharmaceutical industry, the strengthening of data verification to ensure authenticity and objectivity, and the provision of solid data support for industry management work. It is necessary to adhere to a systematic concept, scientifically plan the development path of the pharmaceutical industry in the "15th Five-Year Plan", focus on key areas, and cultivate new quality production forces in the pharmaceutical industry according to local conditions. It is necessary to strengthen the connection between supply and demand, give full play to the service functions of existing platforms, strengthen resource sharing, promote the coordination of production, education, research, and medical use, and the coordinated development of the upstream and downstream of the industrial chain. It is necessary to strengthen the promotion of experience, encourage localities to explore effective measures such as the transformation of pharmaceutical innovation results, and the promotion of the application of innovative drugs and medical devices based on their actual conditions, and continuously create a good ecological environment for the innovative development of the pharmaceutical industry. This article is selected from the official website of the Ministry of Industry and Information Technology; edited by GMTEight: Li Fo.